Latest news
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMTRactigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:56:14 GMTSummit’s Global Bladder Cancer Trial Aims to Enroll About 800 Patients - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMTMapLight’s Schizophrenia Candidate Has Mixed Results at Phase II - Inside Precision MedicineInside Precision Medicine · Mon, 27 Jul 2026 18:39:19 GMTAbelZeta Receives FDA Clearance of Registrational Phase II Trial for C-CAR168 in Refractory Lupus Nephritis - PR NewswirePR Newswire · Mon, 27 Jul 2026 07:00:00 GMT